本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

9.36
+0.31003.43%
盘后9.360.00000.00%16:05 EDT
成交量:119.73万
成交额:1,121.61万
市值:5.11亿
市盈率:-5.68
高:9.60
开:9.07
低:9.05
收:9.05
数据加载中...
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/17

SEC问询函

Form CORRESP - Correspondence
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities